Company Performance Stock Market Corporate Finance Investments Earnings Reports Market Trends Revenue Investment Market Analysis Weight Loss Drugs
Lars Fruergaard Jørgensen will remain temporarily to ensure a smooth transition as the company faces intensified competition and market pressures.